Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52.4M
-
Number of holders
-
136
-
Total 13F shares, excl. options
-
54.6M
-
Shares change
-
+4.93M
-
Total reported value, excl. options
-
$214M
-
Value change
-
-$17.3M
-
Put/Call ratio
-
3.19
-
Number of buys
-
76
-
Number of sells
-
-54
-
Price
-
$3.92
Significant Holders of 2seventy bio, Inc. - Common Stock (TSVT) as of Q3 2023
170 filings reported holding TSVT - 2seventy bio, Inc. - Common Stock as of Q3 2023.
2seventy bio, Inc. - Common Stock (TSVT) has 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.6M shares
.
Largest 10 shareholders include Kynam Capital Management, LP (5.95M shares), BlackRock Inc. (4.42M shares), VANGUARD GROUP INC (3.73M shares), MILLENNIUM MANAGEMENT LLC (3.65M shares), Newtyn Management, LLC (3.08M shares), WELLINGTON MANAGEMENT GROUP LLP (2.99M shares), BAKER BROS. ADVISORS LP (2.5M shares), Casdin Capital, LLC (2.02M shares), Point72 Asset Management, L.P. (1.66M shares), and Madison Avenue Partners, LP (1.49M shares).
This table shows the top 136 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.